Skip to main content

Nephrotic Syndrome: Classification and Evaluation

  • Reference work entry
  • First Online:
Pediatric Nephrology
  • 3861 Accesses

Abstract

Nephrotic syndrome is defined by massive proteinuria, hypoalbuminemia, edema, and hyperlipidemia. Proteinuria is secondary to a defect of the glomerular filtration barrier. The main complications of nephrotic syndrome are infections and thromboembolic events. Although nephrotic syndrome may be secondary to many renal diseases, idiopathic nephrotic syndrome is the most frequent cause in childhood with a complete remission following corticosteroid therapy in 90% of cases. Less frequently, nephrotic syndrome is due to a primary or secondary glomerulonephritis or to a genetic defect of podocyte or glomerular basement membrane proteins. Genetic testing is proposed in children with steroid-resistant idiopathic nephrotic syndrome, children less than 1 year, children with familial history of proteinuria, or those with extrarenal symptoms. Kidney biopsy is performed in children older than 12 years and children who do not respond to steroid therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 1,099.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 549.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Siddall EC, Radhakrishnan J. The pathophysiology of edema formation in the nephrotic syndrome. Kidney Int. 2012;82(6):635–42.

    Article  CAS  Google Scholar 

  2. Deen WM, Lazzara MJ, Myers BD. Structural determinants of glomerular permeability. Am J Physiol Ren Physiol. 2001;281(4):F579–96.

    Article  CAS  Google Scholar 

  3. Miner JH. Glomerular basement membrane composition and the filtration barrier. Pediatr Nephrol. 2011;26(9):1413–7.

    Google Scholar 

  4. Nagata M. Podocyte injury and its consequences. Kidney Int. 2016;89(6):1221–30.

    Article  CAS  Google Scholar 

  5. Guasch A, Deen WM, Myers BD. Charge selectivity of the glomerular filtration barrier in healthy and nephrotic humans. J Clin Invest. 1993;92(5):2274–82.

    Article  CAS  Google Scholar 

  6. Haraldsson B, Nystrom J, Deen WM. Properties of the glomerular barrier and mechanisms of proteinuria. Physiol Rev. 2008;88(2):451–87.

    Article  CAS  Google Scholar 

  7. Carrie BJ, Salyer WR, Myers BD. Minimal change nephropathy: an electrochemical disorder of the glomerular membrane. Am J Med. 1981;70(2):262–8.

    Article  CAS  Google Scholar 

  8. Zhang H, Wang Z, Dong L, Guo Y, Wu J, Zhai S. New insight into the pathogenesis of minimal change nephrotic syndrome: role of the persistence of respiratory tract virus in immune disorders. Autoimmun Rev. 2016;15(7):632–7.

    Article  CAS  Google Scholar 

  9. Davin JC. The glomerular permeability factors in idiopathic nephrotic syndrome. Pediatr Nephrol. 2016;31(2):207–15.

    Google Scholar 

  10. Ponticelli C, Glassock RJ. Glomerular diseases: membranous nephropathy – a modern view. Clin J Am Soc Nephrol. 2014;9(3):609–16.

    Article  Google Scholar 

  11. Almaani S, Meara A, Rovin BH. Update on lupus nephritis. Clin J Am Soc Nephrol. 2017;12(5):825–35.

    Article  Google Scholar 

  12. McAdoo SP, Pusey CD. Anti-glomerular basement membrane disease. Clin J Am Soc Nephrol. 2017;12(7):1162–72.

    Article  CAS  Google Scholar 

  13. Gbadegesin R, Lavin P, Foreman J, Winn M. Pathogenesis and therapy of focal segmental glomerulosclerosis: an update. Pediatr Nephrol. 2011;26(7):1001–15.

    Google Scholar 

  14. Vaziri ND. Molecular mechanisms of lipid disorders in nephrotic syndrome. Kidney Int. 2003;63(5):1964–76.

    Article  Google Scholar 

  15. Agrawal S, Zaritsky JJ, Fornoni A, Smoyer WE. Dyslipidaemia in nephrotic syndrome: mechanisms and treatment. Nat Rev Nephrol. 2018;14(1):57–70.

    Article  CAS  Google Scholar 

  16. Kerlin BA, Haworth K, Smoyer WE. Venous thromboembolism in pediatric nephrotic syndrome. Pediatr Nephrol. 2014;29(6):989–97.

    Google Scholar 

  17. Alwadhi RK, Mathew JL, Rath B. Clinical profile of children with nephrotic syndrome not on glucocorticoid therapy, but presenting with infection. J Paediatr Child Health. 2004;40(1–2):28–32.

    Article  CAS  Google Scholar 

  18. Yamauchi H, Hopper J Jr. Hypovolemic shock and hypotension as a complication in the nephrotic syndrome. Report of ten cases. Ann Intern Med. 1964;60:242–54.

    Article  CAS  Google Scholar 

  19. Jalanko H. Congenital nephrotic syndrome. Pediatr Nephrol. 2009;24(11):2121–8.

    Google Scholar 

  20. Hinkes BG, Mucha B, Vlangos CN, Gbadegesin R, Liu J, Hasselbacher K, et al. Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2). Pediatrics. 2007;119(4):e907–19.

    Article  Google Scholar 

  21. Li AS, Ingham JF, Lennon R. Genetic disorders of the glomerular filtration barrier. Clin J Am Soc Nephrol. 2020;15:1818.

    Article  CAS  Google Scholar 

  22. Vivarelli M, Massella L, Ruggiero B, Emma F. Minimal change disease. Clin J Am Soc Nephrol. 2017;12(2):332–45.

    Article  CAS  Google Scholar 

  23. Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children. Kidney Int. 1978;13(2):159–65.

    Google Scholar 

  24. Trautmann A, Vivarelli M, Samuel S, Gipson D, Sinha A, Schaefer F, et al. IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome. Pediatr Nephrol. 2020;35(8):1529–61.

    Article  Google Scholar 

  25. Watanabe A, Feltran LS, Sampson MG. Genetics of nephrotic syndrome presenting in childhood: core curriculum 2019. Am J Kidney Dis. 2019;74(4):549–57.

    Article  Google Scholar 

  26. Trautmann A, Lipska-Zietkiewicz BS, Schaefer F. Exploring the clinical and genetic spectrum of steroid resistant nephrotic syndrome: The PodoNet Registry. Front Pediatr. 2018;6:200.

    Article  Google Scholar 

  27. Lovric S, Ashraf S, Tan W, Hildebrandt F. Genetic testing in steroid-resistant nephrotic syndrome: when and how? Nephrol Dial Transplant. 2016;31(11):1802–13.

    Article  CAS  Google Scholar 

  28. Preston R, Stuart HM, Lennon R. Genetic testing in steroid-resistant nephrotic syndrome: why, who, when and how? Pediatr Nephrol. 2019;34:195–210.

    Google Scholar 

  29. Floege J, Amann K. Primary glomerulonephritides. Lancet. 2016;387(10032):2036–48.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Niaudet, P. (2022). Nephrotic Syndrome: Classification and Evaluation. In: Emma, F., Goldstein, S.L., Bagga, A., Bates, C.M., Shroff, R. (eds) Pediatric Nephrology. Springer, Cham. https://doi.org/10.1007/978-3-030-52719-8_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-52719-8_24

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-52718-1

  • Online ISBN: 978-3-030-52719-8

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics